GR. Sarantis S.A. · ATHEX:SAR
GR. Sarantis — Sarantis Group — H1 2022 Earnings Presentation
13 slides from GR. Sarantis's earnings presentation, Sep 8, 2022

Slide 1: Sarantis Group Investor & Analyst Conference Call Presentation H1 2022
Sarantis Group Investor & Analyst Conference Call Presentation H1 2022 – September 8th 2022

Slide 2: Disclaimer
Disclaimer This material contains certain “forward-looking” statements. These statements are based on management’s current expectations and are naturally subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained herein and listeners are c

Slide 3: Consolidated Financial Highlights
Consolidated Financial Highlights Consolidated Figures based on Sarantis Group Continuing Activities P&L (€ mil.)* H1 '22 % H1 '21*** Turnover 213.48 9.34% 195.24 Gross Profit 75.02 2.49% 73.20 Gross Profit Margin 35.14% 37.49% EBITDA ** 22.58 -9.60% 24.98 EBITDA Margin 10.58% 12.79% ΕΒΙΤ 16.04 -13.

Slide 4: Balance Sheet & Cash flow
ASSETS Tangible fixed assets H1 ’22 101.12 % 1.22% FY ‘21 99.90 Balance Sheet & Cash flow Right of use 13.56 22.33% 11.09 Investments in property 0.02 -99.50% 4.63 Intangible Assets 58.33 -1.61% 59.29 HEALTHY BALANCE SHEET Goodwill 7.63 -0.44% 7.66 COMMITED BEHIND THE IMPLEMENTATION OF THE GROUP’S S

Slide 5: Significant updates
Significant updates ELCA Cosmetics Ltd sale On June 15 2022 the Group proceeded to the sale of its 49% participation in the JV with The Estée Lauder Companies, ELCA Cosmetics Ltd. This move was in line with The Estée Lauder Companies go-to-market strategy, as well as Sarantis Group strategy of futur

Slide 6: Business Units Analysis
Business Units Analysis -Sarantis Group- Financial Results H1 ‘22 Sep 8th 2022 6

Slide 7: Turnover - SBU Split
Turnover - SBU Split H1 '22 100.00 13.10% 90.00 Other Sales; 12.09% 0.08% 80.00 Private Label; 7.14% 70.00 60.00 50.00 96.24 85.09 Personal Care; 40.00 76.13 76.19 45.08% 14.37% Home Care; 30.00 35.69% 33.12% 20.00 22.57 25.81 10.00 15.24 11.45 0.00 Personal Care Home Care Private Label Other Sales

Slide 8: Turnover - Own vs Distributed Brands Overview
Turnover - Own vs Distributed Brands Overview (€ mil.) H1 ‘22 % Contribution H1 ’22 H1 ‘21 Contribution H1 ‘21 Own brands 153.65 3.48% Distribu 142.26 Distributed ted brands; brands; 27,14% 28,03% Distributed Brands 59.83 12.93% 52.98 Own Own brands; brands; Total 213.48 9.34% 71,97% 195.24 72,86% ✓

Slide 9: EBIT – SBU Split
EBIT – SBU Split H1 '22 12.00 68.54% -41.75% 10.00 Private Label; -0.24% Other Sales; 3.98% 8.00 Home Care; 34.73% 6.00 9.87 9.56 4.00 -68.66% 5.85 5.57 Personal Care; 61.52% -103.44% 2.00 2.04 1.10 0.64 0.00 Personal Care Home Care Private Label Other Sales H1 '21 H1 '22 The Group’s operating profi

Slide 10: Geographical Analysis
Geographical Analysis -Sarantis Group- Financial Results H1 ‘22 Sep 8th 2022 10

Slide 11: Turnover - Country Split
Turnover - Country Split H1 '22 North Macedonia; Slovakia; 1.41% Russia; 0.35% 1.04% Bosnia; 0.83% Ukraine; 4.55% Portugal; 0.38% Greece; 35.77% H1 '21 H1 '22 Hungary; 2.63% 150.00 8.82% Bulgaria; 3.30% 130.00 110.00 Serbia; 4.76% 10.29% 90.00 70.00 137.11 125.99 Czech Republic; 5.43% 50.00 69.25 76

Slide 12: EBIT – Country Overview
EBIT – Country Overview 12.00 H1 '22 -24.15% 10.00 -2.68% 8.00 Foreign Countries 45% 6.00 9.14 9.41 8.90 4.00 7.14 Greece 55% 2.00 - Greece Foreign Countries H1 '21 H1 '22 ✓ The Greek EBIT during H1 2022 reduced by 2.68% to €8.90 mil., from €9.14 mil. in H1 2021, mainly influenced by pressures in th

Slide 13: For more information please visit the Group's Web Site
For more information please visit the Group’s Web Site https://sarantisgroup.com/ or click below to visit the Investor Relations menu: https://sarantisgroup.com/investor-relations/investor-relations/ 13
Source: company website
More decks from GR. Sarantis S.A.
H1 2026 Earnings Presentation21 slides · Sep 9, 2026
Investor Presentation (May 2026)36 slides · May 2026
Investor Presentation (April 2026)36 slides · April 2026
FY2025 Earnings Presentation21 slides · Mar 12, 2026
Investor Presentation (January 2026)33 slides · January 2026
Investor Presentation (December 2025)33 slides · December 2025